Cytosorbents CorporationCTSONASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-16.8%
5Y CAGR-18.3%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-16.8%/yr
vs -27.4%/yr prior
5Y CAGR
-18.3%/yr
Consistent
Acceleration
+10.6pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 2.06 | +18.8% |
| 2023 | 1.73 | -5.8% |
| 2022 | 1.83 | -48.7% |
| 2021 | 3.57 | -41.0% |
| 2020 | 6.06 | +7.3% |
| 2019 | 5.64 | -51.5% |
| 2018 | 11.64 | -9.5% |
| 2017 | 12.87 | -23.7% |
| 2016 | 16.85 | -48.7% |
| 2015 | 32.87 | - |